跳至主要内容
临床试验/PACTR202203544008183
PACTR202203544008183招募中未知

Effect of diclofenac as a prophylactic analgesic during hysterosalpingography in Bayelsa State, South-South Nigeria: a randomized controlled trial

Dr. Peter Chibuzor Oriji0 个研究点目标入组 380 人开始时间: 2022年3月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Infertile women referred for hysterosalpingography, and women that gave consent and completely filled the consent/questionnaire form will be included in the study

排除标准

  • Exclusion criteria included abnormal uterine/vaginal bleeding before the procedure, on-going menstruation, pregnancy, discharge on inspection of the cervix, cervical stenosis/cervical pathology, evidence of pelvic inflammatory disease, previous history of contrast hypersensitivity, history of allergy to diclofenac, and all patients that declined consent or incompletely filled the consent form and questionnaire.

研究者

发起方
Dr. Peter Chibuzor Oriji

相似试验